Explore Our Network

Adipothera develops therapies that repair damaged tissue rather than manage symptoms. We target the stromal microenvironment to address the underlying biology of fibrosis and tissue remodeling. Our lead program addresses radiation-induced skin injury across both medical countermeasure and oncology supportive care settings, with an expanding pipeline in lymphedema and pathological bone formation.

AdraCard develops a proprietary, credit card-sized powder nasal spray platform for rescue medications used in sudden medical emergencies. Rescue medication only works if it is with the patient when the crisis occurs. By designing a device that fits seamlessly into a phone case, wallet, or pocket, AdraCard aims to solve the core problem of non-carriage and complacency, enabling constant access to life-saving medication in conditions such as anaphylaxis, seizure clusters, opioid overdose, hypoglycaemia, and migraine, beginning with adrenaline for anaphylaxis as its lead indication.

Advanced Light Devices manufactures the patent pending Hemealumen Polychromatic Device Innovative Solutions for Treating Infectious and Neurodegenerative Diseases Company Overview Advanced Light Devices is a pioneering company established in the early 2000s, dedicated to developing advanced medical technologies for the treatment of a range of diseases. With a vision to revolutionize healthcare, the company focuses on innovative therapies that utilize light-based technology to address complex medical challenges. The Hemealumen Polychromatic Device At the core of Advanced Light Devices' portfolio is the Hemealumen Polychromatic Device, a state-of-the-art medical tool designed to combat both viral and bacterial diseases. In addition, this device is being used as a therapeutic option for neurodegenerative disorders such as Amyotrophic Lateral Sclerosis (ALS) and Parkinson's disease. Applications in Infectious Disease Treatment The Hemealumen Polychromatic Device has demonstrated effectiveness in treating a variety of infectious diseases, including: Malaria Dengue fever COVID-19 Zika virus Shingles By utilizing targeted polychromatic light, the device disrupts the replication and survival mechanisms of pathogens, offering a non-invasive and innovative approach to disease management. Blood Treatment During Transfusions The Hemealumen Polychromatic Device is also used to treat blood during transfusions, effectively eliminating bacteria and viruses. This process enhances the safety of blood transfusions, reducing the risk of transfusion-transmitted infections and improving patient outcomes. Impact on Neurodegenerative Diseases Beyond infectious diseases, the device shows promise in the management of neurodegenerative conditions such as ALS and Parkinson's disease. Its mechanism of action may help reduce the progression of these disorders, though further research is ongoing to fully understand its therapeutic potential. Conclusion Advanced Light Devices, through the Hemealumen Polychromatic Device, is at the forefront of medical innovation. Their commitment to developing effective treatments for both infectious and neurodegenerative diseases position them as a leader in the field of light-based medical technology.

Advanced Virology specializes in high-fidelity production and engineering of research-grade virus stocks using reverse genetics. The company supports customizable solutions across a broad range of viral families—including wild-type, chimeric, and reporter-expressing viruses. Comprehensive quality assurance and documentation protocols are applied to each batch. Custom services enable the development of tailored virus variants, molecular tags, and reporters to meet research and assay needs.

Amptron Medical Inc. is engaged in developing technologies that enable the monitoring, visualization, and interpretation of physiological signals related to breathing and respiratory health, building toward integrated therapeutic solutions.

Amsel Medical Corporation specializes in the development and commercialization of minimally invasive medical devices for trauma, vascular, and general surgical applications. Its core innovation centers on unique temporary and permanent vessel clamping technologies delivered via needle guidance. For trauma, the company is developing a field-deployable precision hemorrhage control solution for combat and civilian non-compressible junctional hemorrhage injuries . The solution can adjust the degree of vessel occlusion and distal perfusion, minimizing the potential consequences of prolonged limb ischemia and "reperfusion injury", and most importantly extends the "golden hour" for safe evacuation. Saving Limbs...Saving Lives.

AntoXa Corporation is a Canadian biopharmaceutical company that develops plant-based medical countermeasures aimed at protecting military and civilian populations from biological and chemical threats, as well as emerging infectious diseases. Leveraging a proprietary plant molecular farming platform, AntoXa focuses on producing safe, effective, and affordable therapeutics such as antidotes for bioterrorism agents and treatments for pandemic threats. The company specializes in rapid, scalable manufacturing of recombinant proteins and antibodies for use in national stockpiles and public health emergency preparedness.

ArcheMedic Solutions Inc. develops and manufactures portable blood-warming systems designed for use by emergency medical services, military, and civilian medical professionals. The company's patented multi-stage technology enables rapid, precise, and consistent warming of blood in field and remote settings to improve outcomes for trauma patients.

Aridica Corporation is dedicated to advancing immune system research and clinical applications by providing high-quality, automated immune cell isolation solutions. Their mission is to accelerate the development of diagnostics and next-generation therapeutics by simplifying and standardizing the process of immune cell separation. With a focus on automation, reliability, scalability, and sustainability, Aridica aims to empower researchers and clinicians to unlock the full potential of the immune system for improved health outcomes.

ARIScience is at the forefront of drug discovery, leveraging a unique combination of AI, quantum chemistry, computer vision, and biochemistry to develop novel small molecule drugs. Their mission is to reduce the burden of human disease by discovering therapeutics that interrupt disease pathways. With a focus on neurodegenerative, inflammatory, and infectious diseases, ARIScience employs cutting-edge in silico methods to efficiently identify and optimize drug candidates. Their commitment to innovation and collaboration with leading institutions positions them to make a significant impact on human health. ARIScience is creating value in two ways: Value 1: ARIScience is developing small molecule assets targeting respiratory depression, cutaneous burn and radiation injuries, antivirals for EBOV and DENV, bacteriostatic antibiotic targeting Staph aureus. Value 2: It's novel AI driven quasi quantum chemistry (AI+QQ) small molecule discovery platform for precision protein inhibition and potentiation.

ARMR Sciences, Inc. is a biotechnology company dedicated to ending the fentanyl crisis and defending against synthetic drug threats through American innovation. The company is pioneering scalable, preventative immunotherapies to protect individuals before exposure to lethal synthetic drugs like fentanyl, moving beyond reactive treatments to address the root causes of overdose deaths. ARMR's technology is supported by foundational licenses from the Department of Defense and aligns with federal health and defense agencies. The multidisciplinary team brings significant experience from leading institutions and companies such as MindMed, iBio, Ridgeback Biotherapeutics, Scripps Research, Boston Children’s Hospital, Harvard Medical School, and more. United in their vision to save lives, ARMR is committed to providing lasting protection and solving the overdose crisis for millions in need.

Articulate Labs aims to expand physical therapy standards and improve patient outcomes through wearable medical devices. The company uses innovative, agile technology to develop devices that make physical rehabilitation more mobile, convenient, and effective. By integrating technology with everyday activity, Articulate Labs believes patients can conquer functional limitations and better restore physical mobility.

Astrapi Corporation is a leader in revolutionary communication methods, specifically through spiral-based modulation. One capability is the Astrapi Spectrum Analyzer which enables an extremely precise method to measure continuously varying signal power which includes brain waves. This innovative technology is set to transform the next generation of communications by enhancing spectral efficiency and providing new ways to combat channel impairments. Astrapi's technology supports performance advances across various communications networks, including cellular, satellite, and defense communications, among others. Important medical applications of the Astrapi Spectrum Analyzer may include: 1. brain disorder diagnostics and measurement; 2. tumor localization; 3. enhanced prosthetics; and 4. brain-computer interfaces. Astrapi is in the process of spinning out a medical company to focus specifically on the medical applications of its Spectrum Analyzer. We welcome investors and collaborators. Our business model is to license to companies already in the medical field.

Astrocyte Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company dedicated to developing innovative neuroprotection therapies for traumatic brain injuries (TBI), concussions, stroke, and neurodegenerative disorders. The company focuses on harnessing the potential of astrocytes, the brain's natural caretaker cells, to treat brain injuries and diseases. Their flagship program, AST-004, aims to significantly reduce early brain damage and is currently in Phase 2 clinical trials.

Auric Innovations develops emergency medical technologies focused on hemorrhage control, casualty monitoring, and trauma care in both civilian and military environments. The company designs and manufactures medical devices and training systems, including advanced tourniquet platforms, hemorrhage control simulators, and wearable biosensor technologies. Current development efforts include patented networked tourniquet systems capable of transmitting location and physiological data to responders, enabling real-time casualty awareness, automated alerts, and improved decision support during prehospital and battlefield care. Integrated AI models analyze sensor and operational data to assist with triage, injury assessment, and responder decision-making in time-critical environments. Auric Innovations’ technologies are designed for dual-use deployment across military medicine, emergency medical services, law enforcement, and disaster response.

AutonomUS is developing the next generation of interventional medical robotics, with an advanced, AI-enabled system designed to transform how procedures are performed and to expand access to high-quality care. By combining portable, hand-held robotic execution, real-time ultrasound imaging, and intelligent (AI) image interpretation and targeting, AutonomUS aims to improve safety, precision, efficiency, and clinical outcomes across a wide range of interventional medical applications.

Aware Custom Biometric Wearables, is a leading innovator in cutting-edge in-ear technology, specializing in superior custom hearing protection solutions and biometric hearables. Our groundbreaking in-ear solutions feature enhanced hearing capabilities, continuous monitoring, and the collection of medical-grade biometric data, all designed to enhance human performance and safeguard lives. Our commitment to innovation is reflected in our meticulously crafted in-ear devices. Thanks to our patented 3D Ear Scanner technology, we provide a custom fit tailored to the unique shape of each individual's ear which optimizes the performance of sensors. Aware is transforming the ear into a dynamic platform for health and human performance by collecting medical-grade data, delivering actionable AI-driven insights, and enabling precision therapeutics within devices we wear in our everyday lives. Our technology serves a diverse range of sectors within healthcare, military, and industrial. Proudly U.S.-based, offices in Atlanta, GA and San Diego, CA. www.AwareCBW.com.

Bench in a Box Technologies develops point-of-care diagnostic platforms tailored for field and low-resource environments. The company's core technology, Protein Signal Amplification (PSA), allows rapid, electricity-free molecular detection at room temperature, delivering results in five minutes or less, without the need for refrigeration or specialized laboratory infrastructure. Drawing on extensive expertise in molecular diagnostics, drug development, and logistics, the company aims to make high-quality diagnostics broadly accessible.

Berkeley FIT is dedicated to fostering innovation through technology, specializing in AI, software engineering, and digital product design. The company partners with both industry leaders and startups to solve complex challenges, leveraging expertise in modern software development, cloud platforms, AI & machine learning, and user-centered UX/UI design. Their mission is to bridge the gap between current needs and future possibilities by delivering technology-driven solutions with real-world impact.

Biobeat is a global leader in wearable remote patient monitoring technology, revolutionizing hypertension diagnosis and management through innovative, non-invasive, cuff-less blood pressure monitoring systems. Their mission is to ensure all hypertension patients are monitored and managed effectively, empowering healthcare providers with accurate, real-time data to optimize patient care. Biobeat leverages proprietary patented PPG sensor technology and advanced data analytics to deliver continuous, medical-grade monitoring solutions that enhance clinical decision-making, improve patient compliance, and enable proactive interventions. With FDA-cleared and CE-certified devices, Biobeat is committed to transforming healthcare delivery, supporting both in-hospital and home-based care, and driving better patient outcomes worldwide.